Key Developments: DexCom Inc (DXCM.O)

DXCM.O on Nasdaq

94.25USD
2:58pm EDT
Change (% chg)

$0.51 (+0.54%)
Prev Close
$93.74
Open
$92.81
Day's High
$95.67
Day's Low
$92.81
Volume
822,596
Avg. Vol
1,036,936
52-wk High
$98.85
52-wk Low
$38.77

Search Stocks

Latest Key Developments (Source: Significant Developments)

DexCom to Collaborate with the Life Sciences Team at Google on the development of technologies to change the future of diabetes management
Tuesday, 11 Aug 2015 08:00am EDT 

DexCom Inc:Announces that it has entered into an agreement with the life sciences team at Google to jointly develop a series of CGM products that are designed to be smaller and less expensive than existing technologies.Says these new products will incorporate Google's miniaturized electronics platform with DexCom's sensor technology.Says this collaboration also provides an opportunity to better utilize the data generated by these CGM products to significantly improve the outcomes and reduce the costs associated with diabetes care.  Full Article

Dexcom Inc reaffirms FY 2015 revenue guidance-conference call
Wednesday, 29 Apr 2015 04:30pm EDT 

Dexcom Inc:Says it gave product revenue guidance for FY 2015 of between $340 million and $360 million, and it remain quite comfortable with that range.FY 2015 revenue of $360 million - Thomson Reuters I/B/E/S.  Full Article

Dexcom Inc reaffirms FY 2015 revenue guidance - Conference Call
Wednesday, 25 Feb 2015 09:30pm EST 

Dexcom Inc:Says it gave product revenue guidance for FY 2015 of between $340 million and $360 million, and it remain quite comfortable with that range.FY 2015 revenue of $357 million - Thomson Reuters I/B/E/S.  Full Article

Dexcom Inc announces continued partnership with NASCAR Driver Ryan Reed
Thursday, 19 Feb 2015 08:30am EST 

Dexcom Inc:Announces that they are continuing their partnership with NASCAR driver Ryan Reed, the face of the American Diabetes Association's national diabetes awareness initiative, Drive to Stop Diabetes presented by Lilly Diabetes.Through the collaboration, Dexcom will continue its support of Ryan Reed while reinforcing the partners' common quest of creating awareness of CGM among people with diabetes.  Full Article

FDA approves DexCom G4 Platinum Continuous Glucose Monitoring System
Monday, 26 Jan 2015 08:00am EST 

DexCom Inc:Receives U.S. Food and Drug Administration (FDA) approval for its Dexcom G4((reg))PLATINUM Continuous Glucose Monitoring System with Share.  Full Article

DexCom Inc gives FY 2015 revenue guidance in line with analysts' estimates - Conference Call
Tuesday, 13 Jan 2015 06:30pm EST 

DexCom Inc:Expects FY 2015 revenue guidance in a range of $340 million to $360 million.FY 2015 revenue of $351 million - Thomson Reuters I/B/E/S.  Full Article

DexCom Inc announces change in management
Monday, 5 Jan 2015 08:30am EST 

DexCom Inc:Says Kevin Sayer, currently company's President and Chief Operating Officer, has assumed role of President and Chief Executive Officer to succeed Terry Gregg, who is transitioning to role of Executive Chairman after more than 7 years of service as DexCom's President and Chief Executive Officer.  Full Article

DexCom Inc sees FY 2014 revenue guidance to meet or exceed top end of prior range - Conference Call
Thursday, 6 Nov 2014 04:30pm EST 

DexCom Inc:Expects product revenue for FY 2104 to meet or exceed the top end of the range of $235 million.  Full Article

DexCom Inc raises FY 2014 revenue outlook - Conference Call
Wednesday, 6 Aug 2014 04:30pm EDT 

DexCom Inc:Expects FY 2014 product revenue to fall within the range of $220 - $235 mln.FY 2014 revenue of $225 mln - Thomson Reuters I/B/E/S.  Full Article

DexCom Inc reaffirms FY 2014 revenue outlook - Conference Call
Thursday, 1 May 2014 04:30pm EDT 

DexCom Inc:Says it is comfortable with its current FY 2014 revenue guidance at this time.FY 2014 revenue of $221 mln - Thomson Reuters I/B/E/S.  Full Article

Search Stocks